BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 11241055)

  • 21. [A genetic childhood disease with consequences in adult life: the Denys-Drash syndrome].
    Löwik MM; van den Berkmortel FW; Noordam C; van Hamersvelt HW; van den Heuvel LP; Levtchenko EN
    Ned Tijdschr Geneeskd; 2005 Jul; 149(31):1751-5. PubMed ID: 16114294
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genome-wide loss of heterozygosity analysis of WT1-wild-type and WT1-mutant Wilms tumors.
    Ruteshouser EC; Hendrickson BW; Colella S; Krahe R; Pinto L; Huff V
    Genes Chromosomes Cancer; 2005 Jun; 43(2):172-80. PubMed ID: 15761866
    [TBL] [Abstract][Full Text] [Related]  

  • 23. WT1 induces apoptosis through transcriptional regulation of the proapoptotic Bcl-2 family member Bak.
    Morrison DJ; English MA; Licht JD
    Cancer Res; 2005 Sep; 65(18):8174-82. PubMed ID: 16166292
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vascular biology and the sex of flies: regulation of vascular smooth muscle cell proliferation by wilms' tumor 1-associating protein.
    Small TW; Penalva LO; Pickering JG
    Trends Cardiovasc Med; 2007 Oct; 17(7):230-4. PubMed ID: 17936204
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Isolated diffuse mesangial sclerosis and Wilms tumor suppressor gene.
    Ito S; Takata A; Hataya H; Ikeda M; Kikuchi H; Hata J; Honda M
    J Pediatr; 2001 Mar; 138(3):425-7. PubMed ID: 11241056
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High frequency of loss of allelic integrity at Wilms' tumor suppressor gene-1 locus in advanced breast tumors associated with aggressiveness of the tumor.
    Gupta S; Joshi K; Wig JD; Arora SK
    Indian J Cancer; 2009; 46(4):303-10. PubMed ID: 19749460
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bilateral gonadoblastoma with dysgerminoma and pilocytic astrocytoma with WT1 GT-IVS9 mutation: A 46 XY phenotypic female with Frasier syndrome.
    Subbiah V; Huff V; Wolff JE; Ketonen L; Lang FF; Stewart J; Langford L; Herzog CE
    Pediatr Blood Cancer; 2009 Dec; 53(7):1349-51. PubMed ID: 19653292
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Familial extrarenal Wilms tumor.
    Houben CH; Tong JH; Chan AW; Chik KW; Lee KH; Sihoe JD; Tam YH; Yeung CK
    J Pediatr Surg; 2007 Nov; 42(11):1826-30. PubMed ID: 18022431
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic interactions between the Wilms' tumor 1 gene and the p53 gene.
    Menke AL; Clarke AR; Leitch A; Ijpenberg A; Williamson KA; Spraggon L; Harrison DJ; Hastie ND
    Cancer Res; 2002 Nov; 62(22):6615-20. PubMed ID: 12438257
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Wilms' tumor 1 gene expression in hepatocellular carcinoma promotes cell dedifferentiation and resistance to chemotherapy.
    Perugorria MJ; Castillo J; Latasa MU; Goñi S; Segura V; Sangro B; Prieto J; Avila MA; Berasain C
    Cancer Res; 2009 Feb; 69(4):1358-67. PubMed ID: 19190340
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The WT1 Wilms' tumor suppressor gene product interacts with estrogen receptor-alpha and regulates IGF-I receptor gene transcription in breast cancer cells.
    Reizner N; Maor S; Sarfstein R; Abramovitch S; Welshons WV; Curran EM; Lee AV; Werner H
    J Mol Endocrinol; 2005 Aug; 35(1):135-44. PubMed ID: 16087727
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic implications of Wilms' tumor gene (WT1) expression in patients with de novo acute myeloid leukemia.
    Barragán E; Cervera J; Bolufer P; Ballester S; Martín G; Fernández P; Collado R; Sayas MJ; Sanz MA
    Haematologica; 2004 Aug; 89(8):926-33. PubMed ID: 15339675
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Molecular genetics of Wilms' tumor].
    Papezová M; Mares J; Goetz P
    Cas Lek Cesk; 2001 Jun; 140(11):323-7. PubMed ID: 11431850
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Absence of mutations in the Wilms' tumor gene wt1 in de novo non-small cell lung cancers.
    Oji Y; Miyoshi S; Takahashi E; Koga S; Nakano Y; Shintani Y; Hirabayashi H; Matsumura A; Iuchi K; Ito K; Kishimoto Y; Tsuboi A; Ikegame K; Hosen N; Oka Y; Ogawa H; Maeda H; Hayashi S; Kawase I; Sugiyama H
    Neoplasma; 2004; 51(1):17-20. PubMed ID: 15004653
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.
    Zaia A; Fraizer GC; Piantanelli L; Saunders GF
    Anticancer Res; 2001; 21(1A):1-10. PubMed ID: 11299720
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of Wilms tumors in Drash and Frasier syndromes.
    Auber F; Jeanpierre C; Denamur E; Jaubert F; Schleiermacher G; Patte C; Cabrol S; Leverger G; Nihoul-Fékété C; Sarnacki S
    Pediatr Blood Cancer; 2009 Jan; 52(1):55-9. PubMed ID: 18816692
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Absence of PPP2R1A mutations in Wilms tumor.
    Ruteshouser EC; Ashworth LK; Huff V
    Oncogene; 2001 Apr; 20(16):2050-4. PubMed ID: 11360189
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel missense mutation of the Wt1 gene causing Denys-Drash syndrome with exceptionally mild renal manifestations.
    Ohta S; Ozawa T; Izumino K; Sakuragawa N; Fuse H
    J Urol; 2000 Jun; 163(6):1857-8. PubMed ID: 10799199
    [No Abstract]   [Full Text] [Related]  

  • 39. Mutation analysis of the WT1 gene in sporadic childhood leukaemia.
    Algar E; Blackburn D; Kromykh T; Taylor G; Smith P
    Leukemia; 1997 Jan; 11(1):110-3. PubMed ID: 9001425
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Genital malformations of a familial nature].
    Ionescu B; Strihan P; Volcovici G; Augustin M; Ciovîrnache M; Maximilian C
    Stud Cercet Endocrinol; 1965; 16(5):481-6. PubMed ID: 4379381
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.